Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Altus Power Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	29,912	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	54.40%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	32,891	11,901	9,264	5,237	4,683	5,412
Last Close Price	7.00	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	5.93	2.18	3.75	0.93	0.98	1.09
PB Ratio	16.92	5.92	3.27	3.49	2.43	2.35
P/TBV Ratio	17.08	5.99	3.27	3.49	2.43	2.35
P/FCF Ratio	150.17	-	-	-	-	1693.09
P/OCF Ratio	31.18	24.70	-	20.49	-	9.61
EV/Sales Ratio	6.52	2.65	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	15.32	6.07	21.81	54.54	49.41	8.47
EV/EBIT Ratio	16.32	6.50	31.01	-	-	9.86
EV/FCF Ratio	165.13	-	-	-	-	2756.94
Debt / Equity Ratio	2.93	3.26	1.73	4.68	3.05	2.15
Debt / EBITDA Ratio	2.41	2.74	10.33	35.20	35.15	4.64
Debt / FCF Ratio	26.01	-	-	-	-	1551.72
Asset Turnover	0.47	0.41	0.27	-	0.43	0.48
Inventory Turnover	1.22	1.19	0.79	-	1.02	1.12
Quick Ratio	0.34	0.35	0.45	0.48	0.63	1.53
Current Ratio	0.61	0.58	0.76	1.00	1.24	2.28
Return on Equity (ROE)	-51.12%	-42.27%	-108.42%	-	-8.74%	20.13%
Return on Assets (ROA)	11.76%	10.33%	2.24%	-	-0.24%	5.41%
Return on Capital (ROIC)	19.84%	16.40%	3.29%	-	-0.35%	7.60%
Return on Capital Employed (ROCE)	89.00%	85.50%	9.80%	-	-	13.20%
Earnings Yield	-2.83%	-9.05%	-21.68%	-11.97%	-4.12%	8.14%
FCF Yield	0.67%	-3.13%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-2.79%	-	-125.00%	-	-	-
Total Shareholder Return	-	-	-125.00%	-	-	4.17%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.